Followers | 199 |
Posts | 25123 |
Boards Moderated | 0 |
Alias Born | 04/03/2010 |
Thursday, July 14, 2022 4:51:35 PM
They are batches processed in cartridges that are not opened for a reason Hyperopia. They do not need to block other processes from happening, while sitting in one place.
I think the way you construct the process hypothetically, since we are not there, suggests a very static, non-parallel process that suggests zero productivity gain except the presumption you can do more in the same space, which I have always also believed, but not because you’ve got 10 “printer sized” machines going very slowly, in the same space as one clean room, which was basically what you said in the previous post and you did not address here. That’s not fundamentally a productivity gain 1 to 1, which is what the indication was in the sales literature. And if they had meant “because 10
Machines fit into the same space as the average clean room, they would have had to explain that or it would be deceptive.
Ultimately, the main work is done in the cartridge. With feeder and drawing tubes that are attacked for various processes. I believe industrial scale means more serial processing more efficiently, but not necessarily because they have to build 10
different “desktop printers”. I think you’re trying to describe the clinical machines, and coming up a simplified idea of how someone who does not manufacture might imagine a industrial commercial manufacturing process. And it may be that that is version 1.0, I have said that in the past, but it seems to me they have likely done more to the process from their descriptions and also that for some reason, not explained by your descriptions they got 10-15 times more productivity from a machine than a cleanroom. I suspect it is not because they have w bunch of desktop printers laying about. The clinical machine was supposed to be 10 times more efficient than 1 clean room, and I do not believe they ever said, per cubic area or suggested that the productivity gain was presuming multiple machines in the same space. I read all of the literature very carefully when I originally did my own analysis, when all of this first came out.
I just think some may be oversimplifying a layman’s notion of manufacturing and just suggesting they put more machines, 10-15, in the same space. I believe that is not what they were originally saying, and I believe that is not likely the best way that a company would scale a facility that would process these cartridges, but they may need to scale it only as they get more experience with the process. Almost all modern manufacturing starts simply and improves process by process until it is often unrecognizable from the original notions. Putting the process, centering it in a cartridge is a particular idea that makes it a very customizable, potentially highly parallel and serializable process, granted, still each cartridge carefully monitored and managed by set production managers. I think it is unlikely that you’d want to not have a set number at a time for a given manager, probably staggered.
As I said, maybe version 1.0 is a bunch of “desktop printers” each tied up for days, could be. But we don’t have enough information to presume the process that specifically.
Instead, we have numbers they gave us, 1) early productivity numbers from Flaskworks, and the most recent presentation which sets the product limit as they see it. I think, quite honestly, that’s all we can go on, and projections based on web discussions, at this point, is pure speculation and likely not to be accurate.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM